Mirae Asset Global Etfs Holdings Ltd. Biotechnology

Mirae Asset Global Etfs Holdings Ltd.

$47.1 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ATXS Astria Therapeutics, Inc.	$114M	$125,000 0.0% of portfolio	23,393	Q2 2025 Reduced 16.17%
ERAS Erasca, Inc.	$296M	$120,000 0.0% of portfolio	94,986	Q2 2025 Reduced 12.69%
PGEN Precigen, Inc.	$689M	$116,000 0.0% of portfolio	82,085	Q2 2025 Added 0.58%
GLUE Monte Rosa Therapeutics, Inc.	$362M	$115,000 0.0% of portfolio	25,521	Q2 2025 Added 3.66%
CRVS Corvus Pharmaceuticals, Inc.	$341M	$114,000 0.0% of portfolio	28,661	Q2 2025 New
SLS Sellas Life Sciences Group, Inc.	$38.4M	$114,000 0.0% of portfolio	52,210	Q2 2025 New
CDXS Codexis, Inc.	$166M	$111,000 0.0% of portfolio	45,606	Q2 2025 Reduced 4.26%
SGMO Sangamo Therapeutics, Inc	$106M	$111,000 0.0% of portfolio	206,643	Q2 2025 Reduced 28.65%
ALDX Aldeyra Therapeutics, Inc.	$323M	$109,000 0.0% of portfolio	28,592	Q2 2025 Reduced 4.18%
CADL Candel Therapeutics, Inc.	$160M	$108,000 0.0% of portfolio	21,520	Q2 2025 Added 28.49%
FENC Fennec Pharmaceuticals Inc.	$257M	$107,000 0.0% of portfolio	12,917	Q2 2025 Reduced 8.17%
ADCT Adc Therapeutics Sa	$317M	$106,000 0.0% of portfolio	39,633	Q2 2025 Reduced 18.39%
CRDF Cardiff Oncology, Inc.	$94.9M	$106,000 0.0% of portfolio	33,678	Q2 2025 Reduced 1.87%
EDIT Editas Medicine, Inc.	$269M	$104,000 0.0% of portfolio	47,415	Q2 2025 Reduced 71.9%
TRDA Entrada Therapeutics, Inc.	$188M	$103,000 0.0% of portfolio	15,388	Q2 2025 Added 3.98%
OMER Omeros Corp	$277M	$95,000 0.0% of portfolio	31,831	Q2 2025 Reduced 4.22%
YMAB Y M Abs Therapeutics, Inc.	$376M	$95,000 0.0% of portfolio	21,185	Q2 2025 Reduced 4.23%
LIFE A Tyr Pharma Inc	$53.2M	$88,000 0.0% of portfolio	47,643	Q2 2025 New
ELDN Eledon Pharmaceuticals, Inc.	$39.1M	$86,000 0.0% of portfolio	32,052	Q2 2025 New
ENTA Enanta Pharmaceuticals Inc	$214M	$86,000 0.0% of portfolio	11,477	Q2 2025 Reduced 4.54%
FHTX Foghorn Therapeutics Inc.	$193M	$84,000 0.0% of portfolio	17,908	Q2 2025 Added 18.63%
FDMT 4 D Molecular Therapeutics, Inc.	$283M	$81,000 0.0% of portfolio	21,958	Q2 2025 Reduced 16.95%
PBYI Puma Biotechnology, Inc.	$239M	$81,000 0.0% of portfolio	23,765	Q2 2025 Reduced 4.39%
VYGR Voyager Therapeutics, Inc.	$184M	$81,000 0.0% of portfolio	26,347	Q2 2025 Reduced 4.25%
SCPH Sc Pharmaceuticals Inc.	$155M	$71,000 0.0% of portfolio	18,712	Q2 2025 Reduced 18.6%
THRD Third Harmonic Bio, Inc.	$217M	$71,000 0.0% of portfolio	13,214	Q2 2025 Added 11.47%
KOD Kodiak Sciences Inc.	$703M	$69,000 0.0% of portfolio	18,563	Q2 2025 Reduced 4.42%
LRMR Larimar Therapeutics, Inc.	$211M	$69,000 0.0% of portfolio	24,117	Q2 2025 Reduced 4.33%
ALEC Alector, Inc.	$274M	$64,000 0.0% of portfolio	46,286	Q2 2025 Reduced 37.99%
FATE Fate Therapeutics Inc	$117M	$64,000 0.0% of portfolio	57,321	Q2 2025 Reduced 4.24%
DSGN Design Therapeutics, Inc.	$341M	$60,000 0.0% of portfolio	17,957	Q2 2025 Reduced 4.16%
DMAC Dia Medica Therapeutics Inc.	$186M	$56,000 0.0% of portfolio	14,425	Q2 2025 New
PLX Protalix Bio Therapeutics, Inc.	$120M	$56,000 0.0% of portfolio	38,075	Q2 2025 New
TARA Protara Therapeutics, Inc.	$55.9M	$53,000 0.0% of portfolio	17,635	Q2 2025 New
NVCT Nuvectis Pharma, Inc.	$88M	$52,000 0.0% of portfolio	7,029	Q2 2025 New
NKTX Nkarta, Inc.	$104M	$50,000 0.0% of portfolio	30,379	Q2 2025 Reduced 4.18%
CHRS Coherus Bio Sciences, Inc.	$127M	$46,000 0.0% of portfolio	63,861	Q2 2025 Reduced 4.28%
GLSI Greenwich Life Sciences, Inc.	$141M	$31,000 0.0% of portfolio	3,482	Q2 2025 Reduced 4.29%
INMB Inmune Bio, Inc.	$38.2M	$21,000 0.0% of portfolio	9,118	Q2 2025 Added 13.41%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	33,994	Q2 2025 Added 3.77%
GALT Galectin Therapeutics Inc	$253M	$0 0.0% of portfolio	374	Q2 2025 Reduced 91.48%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.